Alerts will be sent to your verified email
Verify Email
INNOVACAP
|
Innova Captab
|
Sequent Scientific
|
Suven Life Sciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
23.11 % | 1.28 % | -65.97 % |
|
5yr average Equity Multiplier
|
2.47 | 2.12 | 1.69 |
|
5yr Average Asset Turnover Ratio
|
1.17 | 0.92 | 0.05 |
|
5yr Avg Net Profit Margin
|
7.98 % | 0.94 % | -798.21 % |
|
Price to Book
|
5.03 | 6.66 | 50.36 |
|
P/E
|
37.62 | 214.47 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
30.74 Days | 55.84 Days | 54.79 Days |
|
Inventory Days
|
52.35 Days | 76.26 Days | 5.7 Days |
|
Days Receivable
|
93.25 Days | 87.51 Days | 32.67 Days |
|
Days Payable
|
105.4 Days | 117.98 Days | 7.08 Days |
|
5yr Average Interest Coverage Ratio
|
10.13 | 2.31 | -218.98 |
|
5yr Avg ROCE
|
25.9 % | 7.29 % | -67.21 % |
|
5yr Avg Operating Profit Margin
|
13.09 % | 8.58 % | -890.08 % |
|
5 yr average Debt to Equity
|
0.58 | 0.5 | 0.01 |
|
5yr CAGR Net Profit
|
27.62 % | n/a | 2.21 % |
|
5yr Average Return on Assets
|
9.22 % | 0.71 % | -37.69 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
50.9 % | 52.61 % | 70.27 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.41 % | 5.29 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
7.35 % | 9.92 % | 0.0 |
|
Innova Captab
|
Sequent Scientific
|
Suven Life Sciences
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
Segment Break-Up
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|